Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.

Scandinavian Journal of Gastroenterology
L E HanssenL O Dolva

Abstract

Nineteen patients with histologically verified midgut carcinoid tumours and liver metastases were included in a prospective study with daily recombinant human alpha 2b interferon injections of 5 million IU subcutaneously for 1 year. All had as much as possible of the primary tumour removed at laparotomy. Whenever technically possible (in seven cases), an embolization of the hepatic arteries was performed before interferon start. The response rate of the combined embolization and interferon treatment (n = 7) was 86% after 1 year, as judged from either a 50% reduction in excretion of 5-hydroxy-3-indoleacetic acid in the urine or a 50% reduction in the area of the largest liver metastasis as evaluated by computed tomography. All patients experienced an improvement in diarrhoea and/or flushing. When interferon was given alone (n = 12), 40% responded on the basis of objective criteria (50% after 6 months), whereas an improvement in either diarrhoea or flushing was experienced by 70% (75% after 6 months). In this group one patient had died and one had decided to withdraw after 6 months, at which time both were responders. We conclude that interferon seems to be an effective treatment of malignant metastatic midgut carcinoid tumours a...Continue Reading

References

Sep 20, 1979·World Journal of Surgery·B M Jaffe
May 1, 1978·The British Journal of Surgery·M J SwornR Buchanan
Aug 1, 1975·Cancer·J D Godwin
Aug 30, 1985·Biochemical and Biophysical Research Communications·E Theodorsson-NorheimP G Lindgren
Feb 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R QuesadaJ U Gutterman
Sep 1, 1986·The Journal of Clinical Endocrinology and Metabolism·I NorheimK Oberg
Sep 11, 1986·The New England Journal of Medicine·L K KvolsR G Hahn
Jun 28, 1986·Lancet·J R Quesada, J U Gutterman
Mar 1, 1986·International Journal of Radiation Oncology, Biology, Physics·W E SamlowskiW T Sause
Jun 1, 1986·Australian and New Zealand Journal of Medicine·P Hersey
Jun 1, 1985·Radiology·H A MittyI H Parnes
Dec 29, 1973·British Medical Journal·I M Murray-LyonR Williams
Dec 31, 1984·Journal of Immunological Methods·W P ProtzmanD K Kelsey
Nov 1, 1981·International Journal of Radiation Oncology, Biology, Physics·T J KeaneB J Cummings
Aug 1, 1982·Journal of Clinical Microbiology·T J YehJ A Green
Nov 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C G Moertel
Nov 1, 1984·Journal of Surgical Oncology·H MårtenssonG Sandén
Oct 1, 1983·British Medical Journal·P N MatonV S Chadwick
Jan 1, 1983·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·S BengmarkK G Tranberg
May 1, 1982·Archives of Surgery·J ZeitelsF Straus
Sep 1, 1961·Cancer·C G MOERTELA H BAGGENSTOSS
Oct 1, 1959·The American Journal of Medicine·O D KOWLESSARM H SLEISENGER

❮ Previous
Next ❯

Citations

Mar 1, 1997·Diseases of the Colon and Rectum·P C NearyD Bouchier-Hayes
May 11, 1991·Annals of Surgery·B M EversJ C Thompson
Jun 3, 2014·Journal of Experimental & Clinical Cancer Research : CR·Michela Del PreteUNKNOWN Multidisciplinary Group for NeuroEndocrine Tumors of Naples
Sep 23, 2008·Expert Opinion on Pharmacotherapy·I M ModlinB I Gustafsson
Mar 25, 2015·Scandinavian Journal of Gastroenterology·Lars Aabakken
Apr 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Irvin M ModlinGeeta Eick
Sep 15, 1994·Annals of the New York Academy of Sciences·K ObergE T Janson
Sep 15, 1994·Annals of the New York Academy of Sciences·B M EversJ C Thompson
Jun 8, 2004·Endocrine Reviews·Gregory A KaltsasAshley B Grossman
Sep 22, 2019·Cancers·Vincent LaroucheShereen Ezzat
Jun 1, 1992·Scandinavian Journal of Gastroenterology·J E GrønbechA Bergan
Nov 1, 1991·The British Journal of Dermatology·J FunkL E Hanssen
May 1, 1991·Scandinavian Journal of Gastroenterology·F KolmannskogL E Hanssen
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·C B Lamers
Dec 15, 2015·Asia-Pacific Journal of Clinical Oncology·Marinos PericleousChristos Toumpanakis
Oct 1, 1994·Cancer Treatment Reviews·K Oberg
Feb 1, 1993·American Journal of Surgery·M D BassonI M Modlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H JoensuuP Gröhn
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H ScherüblU Räth
© 2022 Meta ULC. All rights reserved